4EJN: Crystal Structure Of Autoinhibited Form Of Akt1 In Complex W (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h-Imidazo[4 B]Pyridin-3-Yl)Benzyl)-3-Fluorobenzamide
reference: Discovery and Optimization of a Series of 3-(3-Phenyl-3H-imidazo[4,5-b]pyridin-2-yl) pyridin-2-amines: Orally Bioavailable, Selective and Potent ATP-independent Akt Inhibitors., Ashwell MA, Lapierre JM, Brassard C, Bresciano K, Bull C, Cornell-Kennon S, Eathiraj S, France D, Hall T, Hill J, Kelleher E, Khanapurkar S, Kizer D, Koerner S, Link J, Liu Y, Makhija S, Moussa M, Namdev N, Nicewonger R, Nguyen K, Palma R, Szwaya J, Tandon M, Uppalapati U, Vensel D, Volak LP, Volckova E, Westlund N, Wu H, Yang RY, Chan TC, J Med Chem. 2012 Apr 25. PMID: 22533986

This OCA Structure page
uses Jmol, developed by the Jmol Development Team (documentation).